Trevor Hallam
2019 - SUTRO BIOPHARMA
In 2019, Trevor Hallam earned a total compensation of $1M as Chief Scientific Officer at SUTRO BIOPHARMA, a 77% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $150,480 |
|---|---|
| Option Awards | $330,600 |
| Salary | $418,000 |
| Other | $132,000 |
| Total | $1,031,080 |
Hallam received $418K in salary, accounting for 41% of the total pay in 2019.
Hallam also received $150.5K in non-equity incentive plan, $330.6K in option awards and $132K in other compensation.
Rankings
In 2019, Trevor Hallam's compensation ranked 9,149th out of 13,971 executives tracked by ExecPay. In other words, Hallam earned more than 34.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,149 out of 13,971 | 35th |
Division Manufacturing | 3,671 out of 5,701 | 36th |
Major group Chemicals And Allied Products | 1,389 out of 2,200 | 37th |
Industry group Drugs | 1,186 out of 1,886 | 37th |
Industry Biological Products, Except Diagnostic Substances | 267 out of 389 | 31st |
Source: SEC filing on April 24, 2020.
Hallam's colleagues
We found four more compensation records of executives who worked with Trevor Hallam at SUTRO BIOPHARMA in 2019.
News
SUTRO BIOPHARMA CEO William Newell's 2021 pay jumps 161% to $5.6M
April 22, 2022
SUTRO BIOPHARMA CEO William Newell's 2020 pay falls 44% to $2.2M
April 29, 2021
SUTRO BIOPHARMA CEO William Newell's 2019 pay falls 56% to $3.8M
April 24, 2020
SUTRO BIOPHARMA CEO William Newell's 2018 pay jumps 1,136% to $8.7M
April 25, 2019